Search

OBJECTIVE Given the lack of a Korean version of the Spinal Cord Independence Measure III (KSCIM-III) that accurately reflects the contextual and cultural aspect of the assessment tool, the aims of the study were to develop a new Korean version of the Spinal Cord Independence Measure III and to investigate its reliability and validity. DESIGN Forty (N = 40) consecutive patients with spinal cord injury were included in this prospective study. Backward and forward translation of the Spinal Cord Independence Measure III was performed by fluent speakers in both languages. To measure the validity of Korean version of the Spinal Cord Independence Measure III, the scores were compared with the Modified Barthel Index. Each patient was examined by two occupational therapists. For test-retest reliability assessment, follow-up evaluation was repeated 1 mo after the initial assessment by the same evaluator. RESULTS Reliability between the Korean version of the Spinal Cord Independence Measure III evaluators showed values of 0.710-1.000, and test-retest reliability showed high values ranging from 0.295 to 0.664. The validity of Korean version of the Spinal Cord Independence Measure III was confirmed by the close correlation with Modified Barthel Index (r = 0.953, P < 0.001). CONCLUSIONS The results of this study showed high interrater and substantial test-retest reliability. The Korean version of the Spinal Cord Independence Measure III is an appropriate tool to assess the activities of daily living in terms of independence for patients with spinal cord injury.

Summary Hutchinson‐Gilford progeria syndrome (HGPS) constitutes a genetic disease wherein an aging phenotype manifests in childhood. Recent studies indicate that reactive oxygen species (ROS) play important roles in HGPS phenotype progression. Thus, pharmacological reduction in ROS levels has been proposed as a potentially effective treatment for patient with this disorder. In this study, we performed high‐throughput screening to find compounds that could reduce ROS levels in HGPS fibroblasts and identified rho‐associated protein kinase (ROCK) inhibitor (Y‐27632) as an effective agent. To elucidate the underlying mechanism of ROCK in regulating ROS levels, we performed a yeast two‐hybrid screen and discovered that ROCK1 interacts with Rac1b. ROCK activation phosphorylated Rac1b at Ser71 and increased ROS levels by facilitating the interaction between Rac1b and cytochrome c. Conversely, ROCK inactivation with Y‐27632 abolished their interaction, concomitant with ROS reduction. Additionally, ROCK activation resulted in mitochondrial dysfunction, whereas ROCK inactivation with Y‐27632 induced the recovery of mitochondrial function. Furthermore, a reduction in the frequency of abnormal nuclear morphology and DNA double‐strand breaks was observed along with decreased ROS levels. Thus, our study reveals a novel mechanism through which alleviation of the HGPS phenotype is mediated by the recovery of mitochondrial function upon ROCK inactivation.